Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mulugeta Seneshaw

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
JHEP Reports : Innovation in Hepatology|April 16, 2026
Disease-driven loss of inactive HSD17B13 isoforms enhances enzymatic output in MASH and counters protective rs72613567:TA variantJohn Min, Mulugeta Seneshaw, Faridoddin Mirshahi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2017
The multifaceted role of natriuretic peptides in metabolic syndromePrasanna K Santhekadur, Divya P Kumar, Mulugeta Seneshaw, et al.
Hepatology (Baltimore, Md.)|November 6, 2018
A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular CarcinomaDivya P Kumar, Prasanna K Santhekadur, Mulugeta Seneshaw, et al.
Scientific Reports|July 2, 2025
Sexual dimorphism of MASLD-driven bone lossGalen M Goldscheitter, Mulugeta Seneshaw, Faridoddin Mirshahi, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Sexual dimorphism of MASLD-driven bone lossGalen M Goldscheitter, Mulugeta Seneshaw, Faridoddin Mirshahi, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|April 3, 2023
Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver DiseaseNicole Ng, Dean Tai, Yayun Ren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 24, 2025
Anti-Tumour Immunity Relies on Targeting Tissue Homeostasis Through Monocyte-Driven Responses Rather Than Direct Tumour CytotoxicityNicholas Koelsch, Faridoddin Mirshahi, Hussein F Aqbi, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
Anti-tumor immunity relies on targeting tissue homeostasis through monocyte-driven responses rather than direct tumor cytotoxicityNicholas Koelsch, Faridoddin Mirshahi, Hussein F Aqbi, et al.
Research Square|December 8, 2025
MASLD and MASH increase fracture risk in humans and mice by arresting new bone formationGalen Goldscheitter, Vinay Jahagirdar, Mulugeta Seneshaw, et al.
Journal of Visualized Experiments : Jove|August 9, 2016
Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density LipoproteinMulugeta Seneshaw, Faridoddin Mirshahi, Hae-Ki Min, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
JHEP Reports : Innovation in Hepatology|April 16, 2026
Disease-driven loss of inactive HSD17B13 isoforms enhances enzymatic output in MASH and counters protective rs72613567:TA variantJohn Min, Mulugeta Seneshaw, Faridoddin Mirshahi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2017
The multifaceted role of natriuretic peptides in metabolic syndromePrasanna K Santhekadur, Divya P Kumar, Mulugeta Seneshaw, et al.
Hepatology (Baltimore, Md.)|November 6, 2018
A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular CarcinomaDivya P Kumar, Prasanna K Santhekadur, Mulugeta Seneshaw, et al.
Scientific Reports|July 2, 2025
Sexual dimorphism of MASLD-driven bone lossGalen M Goldscheitter, Mulugeta Seneshaw, Faridoddin Mirshahi, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Sexual dimorphism of MASLD-driven bone lossGalen M Goldscheitter, Mulugeta Seneshaw, Faridoddin Mirshahi, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|April 3, 2023
Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver DiseaseNicole Ng, Dean Tai, Yayun Ren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 24, 2025
Anti-Tumour Immunity Relies on Targeting Tissue Homeostasis Through Monocyte-Driven Responses Rather Than Direct Tumour CytotoxicityNicholas Koelsch, Faridoddin Mirshahi, Hussein F Aqbi, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
Anti-tumor immunity relies on targeting tissue homeostasis through monocyte-driven responses rather than direct tumor cytotoxicityNicholas Koelsch, Faridoddin Mirshahi, Hussein F Aqbi, et al.
Research Square|December 8, 2025
MASLD and MASH increase fracture risk in humans and mice by arresting new bone formationGalen Goldscheitter, Vinay Jahagirdar, Mulugeta Seneshaw, et al.
Journal of Visualized Experiments : Jove|August 9, 2016
Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density LipoproteinMulugeta Seneshaw, Faridoddin Mirshahi, Hae-Ki Min, et al.
Pageof 2